NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/24/2024
Back to search
Official data from USPTO
GENESEQ: CARDIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENESEQ: CARDIO
ST13
US500000085679085Class
42, 44
Filing
85679085
Registration
4502416
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/24/2024
Trademark type
Word
Nice classes
42, 44
Filing date
07/17/2012
Registration date
03/25/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/24/2024
Last transaction
06/24/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-01-00
First use in commerce
2013-01-00
Drawing code
4
Owner type
03
Owner location
Burlington, NC, US
Examiner
SINGH, TEJBIR
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Laboratory Corporation of America Holdings
Representatives
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical laboratory services for diagnostic purposes; development of therapy guidance toolsdrug susceptibility resistance tests for guiding the treatment of diseases
Class 44
Medical testing for diagnostic purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/24/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/24/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
03/25/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/25/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/09/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2020
E815
TEAS SECTION 8 & 15 RECEIVED
03/17/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/25/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/15/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/14/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/14/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/13/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/12/2014
EX1G
SOU EXTENSION 1 GRANTED
02/12/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/07/2014
IUAF
USE AMENDMENT FILED
01/07/2014
EXT1
SOU EXTENSION 1 FILED
01/07/2014
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2014
EISU
TEAS STATEMENT OF USE RECEIVED
01/07/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/09/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2013
PUBO
PUBLISHED FOR OPPOSITION
05/14/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2013
ALIE
ASSIGNED TO LIE
03/27/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/26/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/24/2012
GNRT
NON-FINAL ACTION E-MAILED
10/24/2012
CNRT
NON-FINAL ACTION WRITTEN
10/24/2012
DOCK
ASSIGNED TO EXAMINER
10/24/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2012
NWAP
NEW APPLICATION ENTERED
07/20/2012
Continuous trademark protection
Get notified about every new filing that threatens GENESEQ: CARDIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.